The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition
Description
This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, represents the 11th edition of this comprehensive look at the IVD industry. At 1,800 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles hundreds of competitors, notes significant acquisitions and other deals, discusses trends and breaks out regional and country markets. The report provides market size and forecasts to 2023 for defined segments of the IVD market and various sub-segments. The 1,800-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market.
Current 2018 IVD Market Estimates For Essential Segments
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2023 for defined segments of the IVD market and various sub-segments, including:
• Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
• Clinical Chemistry and "Core Lab" Markets (including sub segment revenues for General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care)
• Point-of-Care Testing (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other)
• Substance Abuse Testing
• Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
• Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
• Tissue-Based Testing - Histology and Cytology (Pap, ISH, IHC, HPV)
• Infectious Disease Immunoassay Testing (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others)
• Hematology
• Flow Cytometry
• Molecular Tests in Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others)
• Non-Infectious Disease Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D)
• Coagulation Tests (Lab-Based, POC, Genetic Markers)
• Mass Spectrometry
• Molecular Point-Of-Care
• Next Generation Sequencing
• Direct-to-Consumer Testing
The report also tracks hundreds of competitors, notes significant partnerships, distribution deals and acquisitions and defines the market share situation for the in vitro diagnostic market and competitive analysis for many segments.
The Future of IVD: Market Segment Projections to 2023
For each of the listed in vitro diagnostics market segments, 2018 in vitro diagnostics market size, 2023 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers' product innovations. The market data is put into a context with real-world industry and medical practice trends. The Worldwide Market for In Vitro Diagnostic Tests has been called "The Bible of the IVD Industry" by customers, which include top IVD firms. Using Kalorama Information's The Worldwide Market for In vitro Diagnostic (IVD) Tests, 11th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.
The Global Market Regional and Country IVD Markets
The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers' product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:
• US
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Netherlands
• Turkey
• Poland
• Canada
• China
• Japan
• Saudi Arabia
• Brazil
• Eastern Europe
• Emerging Markets
• Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2018.
Superior In Vitro Diagnostic Company Profiles
Kalorama Information's report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition contains hundreds of profiles of companies operating within the in vitro diagnostics industry. Top-tier IVD companies such as Roche Diagnostics, Abbott, Siemens, Beckman Coulter, bioMerieux, Qiagen and Ortho Clinical Diagnostics are discussed at great length and hundreds of smaller companies are detailed. Modest in vitro diagnostics technology growth in developed countries, stronger growth in developing countries with a simultaneous shift from a preoccupation with infectious diseases to chronic conditions, is expected. Also discussed within the report is increased privatization of healthcare services throughout the world, developed and emerging economies included and thus increased pricing pressure on all devices including in vitro diagnostics technology.
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.
---
Reserve Your Copy Today!
For access to past editions, and Kalorama's library of reports
ask about our KNOWLEDGE CENTER for your organization
---
The report covers both the dominant companies in the in vitro diagnostics industry and the fast up-and-comers for a complete picture of the market. For each company, extensive, discussion of recent financial performance is provided. These IVD manufacturers' main products are detailed and any significant company strategies, partnerships and acquisitions are considered:
• Abbott Diagnostics
• Beckman Coulter, Inc. / Danaher
• Becton, Dickinson and Company (BD)
• bioMérieux Inc.
• Bio-Rad Laboratories
• Hologic
• Instrumentation Laboratory (IL)
• Ortho Clinical Diagnostics (OCD)
• QIAGEN N.V
• Roche Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Thermo FisherScientific
• Werfen Group S.A.
• ERBA Diagnostics, Inc
• DiaSorin S.p.A
• Illumina
• Luminex Corporation
• Menarini Diagnostics.
• Mindray Medical International Limited
• Myriad Genetics
• Perkin Elmer, Inc. (PE)
• Quidel Corporation
• Randox Laboratories Ltd
• Royal Philips
• TOSOH Corporation
• Trinity Biotech
• Wako Pure Chemical Industries
Table of Contents
1812 Pages
- The Worldwide IVD Market, 2018 -2023 ($millions)
- Scope and Methodology
- Size and Growth of the Market
- Competitive Picture in IVD
- IVD Market Highlights
- What to Watch in the Future
- Lab Medicine Disciplines and Applications
- A Paradox of Sorts
- Report Design
- The Challenge of PAMA
- Market Analysis of IVD Market Segments
- Top Suppliers and Niche Players
- IVD Companies Mix and Match
- Market Expansion Initiatives
- Distribution Agreements
- Licenses and Collaboration Agreements
- Test Services
- IVDs Then and Now – A 22 Year Perspective
- Point of View
- Background
- The Aging Planet
- Shifting Disease Burdens
- Emerging and Emerged Markets
- Size and Forecast for the World IVD Market
- The IVD Market in the United States
- IVD Market in Europe: Limited Recovery
- Opportunity in Eastern Europe
- Japan: Second-Largest Country Market
- China: Largest High-Growth Market
- India: Home to Every Sixth Person in the World
- Rest of Asia
- Brazil: LATAM Leader
- Mexico
- The Russian Federation
- Canada
- Emerging Markets
- Introduction
- Gene Editing
- Microbiome
- Liquid Biopsy
- Information Technology Takes Center Stage
- Exosome Sequencing
- Biotin Interference in Immunoassay Detection Errors
- Single Drop Blood Tests
- Regulators Clear a Path for Diagnostic Next Generation Sequencing
- High-Sensitivity Cardiac Troponin Tests Finally Reach the U.S.
- Lab Test Harmonization Gets a $2 Million Boost
- Traumatic Brain Injury and IVD
- Blockchain
- Substance Abuse
- Overview and Trends
- The Major POC Test Players
- POC Infectious Disease Testing
- Diabetes Testing – Blood Glucose Monitoring
- Drug of Abuse Testing
- Core Lab Overview and Trends
- Connectivity
- Overview of Chemistry Tests
- Market Analysis
- Sleep Apnea Testing: Core Lab Solution?
- The Commercial Outlook for Chemistry Tests
- Overview and Trends
- Market Analysis
- Mature Assay Segment
- Maturing Immunoassays
- Growth Immunoassays
- The Commercial Outlook for Immunoassays
- Overview
- Sample Preparation and Quality Control
- Advanced Molecular Tests and Technologies
- Major Players
- Market Analysis
- The Commercial Outlook for Molecular Tests
- Overview of Hematology and Trends
- Laboratory-based Hematology Testing
- Decentralized Hematology Testing
- Market Analysis: Leading Suppliers
- The Commercial Outlook for Hematology Tests
- Overview and Trends of Coagulation and Immunohematology Tests
- Special Topics
- Market Analysis
- Lab-based Testing
- Leading Suppliers: Laboratory Systems
- Decentralized Coagulation Testing – Professional Use
- Leading Suppliers: POC Systems
- The Commercial Market for Coagulation Tests
- The Burden of Infectious Disease
- Hidden Costs of Non-Detection: Secondary Effects
- Microbial Antibiotic Resistance – The Role of Clinical Tests
- Traditional Microbiology and Its Limits
- New Microbiology - Innovations
- Emerging Infectious Disease Threats
- Microbiology Firms Mix and Match
- Market Analysis
- Market Analysis - Traditional Microbiology ID/AST
- Market Analysis - Microbiology Immunoassays
- Market Analysis - Molecular Microbiology
- Mass Spectrometry
- The Future Outlook for Microbiology
- Introduction
- The Current Status of Global Blood Collection
- Global Blood Safety
- Blood and Component Collection
- Reevaluating Blood Transfusions
- Blood Typing and Grouping Market
- Blood Testing Market
- The Commercial Outlook for Blood Banking Testing
- Overview
- Special Topics
- Market Analysis
- The Commercial Outlook for Histology and Cytology Tests
- Abbott Diagnostics
- Arkray
- Beckman Coulter, Inc. / Danaher
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin S.p.A.
- Grifols S.A.
- Hologic, Inc.
- Instrumentation Laboratory (IL) / Werfen
- Ortho Clinical Diagnostics (Ortho)
- QIAGEN N.V.
- Radiometer A/S / Danaher
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Werfen
- Agilent Technologies
- BGI Genomics (formerly Beijing Genome Institute)
- Cepheid / Danaher
- Eiken Chemical Co., Ltd
- FUJIFILM Wako Pure Chemical Corporation
- Fujirebio Diagnostics, Inc.
- Illumina
- LabCorp, Laboratory Corporation of America
- Luminex Corporation
- Meridian Bioscience, Inc.
- Mindray Medical International Limited
- PerkinElmer, Inc. (PE)
- Philips (Royal Philips)
- Quest Diagnostics
- Quidel Corporation
- Randox Laboratories Ltd.
- Ventana Medical Systems Inc. / Roche Tissue Diagnostics
- Bloodsource
- Cerus Corporation
- Haemokinesis Pt
- Immucor
- MicroTyping Concepts
- Micronics
- Quotient Limited
- Reliance Life Sciences
- Diagnostica Stago, S.A.S.
- Microvisk Technologies
- DIAGON Kft. Hungary
- AB SCIEX Pte Ltd.
- EKF Diagnostics Holdings Plc
- ELITech Group S.A.S.
- ERBA Diagnostics, Inc.
- MedTest DX
- Microsaic Systems plc
- Nova Biomedical
- Scienion AG
- Sekisui Diagnostics
- Shimadzu Scientific Instruments
- Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
- Tecan Group
- Tosoh Bioscience
- Trinity Biotech Plc
- Angle, plc
- Biocartis
- Biocept, Inc.
- Biodesix
- Cynvenio Biosystems
- Epic Sciences
- Epigenomics AG
- Foundation Medicine, Inc.
- Genomic Health
- Guardant Health, Inc.
- Menarini-Silicon Biosystems
- Myriad Genetics, Inc.
- Natera
- NeoGenomics
- Animas Corporation
- Ascensia Diabetes Care Holdings AG
- Bigfoot Biomedical Inc.
- Cellnovo Group SA
- Debiotech SA
- Dexcom Inc.
- Gentag Inc.
- Glooko Inc.
- GlySure Limited
- Glytec LLC
- iHealth Labs Inc.
- Insulet Corporation
- Integrity Applications Inc.
- LifeScan Inc.
- Medtronic plc
- Nemaura Medical Inc.
- Nightscout Project
- Sanofi
- Trividia Health Inc.
- Verily Life Sciences LLC
- CellaVision AB
- Horiba Medical
- Medica Corporation
- Onca Xt Ltd
- West Medica
- Advanced Cell Diagnostics (ACD)
- Amoy Diagnostics Co. Ltd.
- Applied Spectral Imaging Inc. (ASI)
- BioGenex Laboratories, Inc.
- BioView Ltd.
- Circulomics Inc.
- Dako A/S
- Definiens
- HTG Molecular Diagnostics
- Kapa Biosystems Inc.
- Leica Biosystems
- MilliporeSigma (formerly EMD Millipore)
- Omnyx LLC
- Visiopharm
- BG Medicine, Inc
- Binding Site Group Ltd. (The)
- Biohit Oyj (Biohit Healthcare)
- Biomerica Inc.
- Bio-Techne Corporation
- Corgenix Medical Corporation
- Critical Diagnostic
- Diaxonhit (Eurobio scientific)
- EUROIMMUN AG
- HOB Biotech
- Immunodiagnostic Systems (IDS)
- INOVA Diagnostics, Inc.
- Integrated Diagnostics (now Biodesix)
- One Lambda
- Orgentec Diagnostika
- Protagen Diagnostics
- Response Biomedical Corp.
- Singulex, Inc.
- Theradig
- VolitionRx Limited
- Advaita Corp.
- Cerner Corp.
- Dell Technologies Inc.
- Desktop Genetics Ltd.
- DNAnexus Inc.
- Edico Genome
- Euformatics Oy
- Genalice
- GenomOncology LLC
- Google LLC
- Human Longevity Inc.
- Internation Business Machines Corp. (IBM)
- Intel Corporation
- N-of-One
- PierianDx
- Rennova Health, Inc.
- SOPHiA GENETICS SA
- Sunquest Information Systems Inc.
- WuXi NextCODE
- Accelerate Diagnostics, Inc.
- Advanced Biological Laboratories, S.A. (ABL)
- AdvanDx, Inc.
- altona Diagnostics
- ArcDia International Oy Ltd.
- BioFire Diagnostics, LLC. (Acquired by bioMérieux)
- Bruker BioSciences Corporation
- COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
- Curetis
- Fast Track Diagnostics (Acquired by Siemens Healthineers)
- Focus Diagnostics, Inc.
- Genetic Analysis AS
- GeneWeave Biosciences, Inc.
- Greiner Bio-One International GmbH
- Hain Lifescience GmbH
- Mast Group
- Mobidiag Ltd.
- Nanosphere, Inc. (Luminex)
- PositiveID Corporation
- Q-linea AB
- Seegene, Inc.
- Specific Technologies
- Synbiosis Ltd.
- T2 Biosystems
- ViroCyt, LLC
- Asuragen Inc.
- AutoGenomics Inc.
- Enzo Biochem Inc.
- Exosome Diagnostics, Inc.
- Fluidigm Corporation
- GenMark Diagnostics, Inc
- Genome Diagnostics BV (GenDx)
- Nanostring Technologies, Inc.
- Oxford Nanopore Technologies Ltd
- Pacific Biosciences of California, Inc. (PacBio)
- QuanDx Inc
- RainDance Technologies, Inc.
- Rubicon Genomics, Inc.
- Takara Bio Inc.
- Trovagene, Inc.
- Vela Diagnostics
- WaferGen Bio-systems, Inc.
- Abaxis, Inc.
- Abingdon Health Ltd.
- Atlas Genetics Ltd.
- Biomeme, Inc.
- Chembio Diagnostic Systems, Inc.
- DNA Electronics Ltd (DNAe)
- Entopsis
- FABPulous B.V.
- Fio Corporation
- genedrive plc (formerly Epistem Holdings)
- Hema Diagnostic Systems (HDS; dba NuGenerex Diagnostics)
- Imec
- InSilixa Inc.
- Loop Medical (formerly QloudLab SA)
- MedMira, Inc.
- OraSure Technologies, Inc.
- PTS Diagnostics
- QuantuMDx Group, Ltd.
- Rheonix, Inc.
- Samsung Healthcare
- Veredus Laboratories Pte Ltd
- Affymetrix, Inc.
- Berry Genomics Co. ltd.
- CombiMatrix (Invitae)
- CooperGenomics (Division of CooperSurgical)
- Counsyl
- GenePeeks, Inc.
- Genetadi Biotech S.L.
- Genoma Group
- Innovations Exchange Pte Ltd (INEX) and iGene Diagnostics Pte Ltd
- LifeCodexx AG
- Oxford Gene Technology
- Premaitha Health
- Ravgen
- Reproductive Genetics Innovations
- Sequenom, Inc.
- 10x Genomics
- Agena Bioscience, Inc.
- Biotype Diagnostic GmbH
- DxTerity Diagnostics Inc.
- Horizon Discovery Group plc
- IncellDx
- Oasis Diagnostics Corporation
- Precipio, Inc. (formerly Transgenomic)
- PreAnalytiX GmbH
- Quanterix Corporation
- SeraCare Life Sciences, Inc.
- Streck Inc.
- 23andMe
- Agendia BV
- Ambry Genetics
- ARUP Laboratories
- Assurex Health
- The BioCollective
- BioReference Laboratories
- Biotheranostics
- BluePrint Genetics Oy
- Boston Heart Diagnostics
- CareDx, Inc.
- Cleveland HeartLab Inc.
- Eurofins Genomics
- Exact Sciences Corp.
- Genomic Vision
- Helomics Corporation
- Mayo Medical Laboratories
- MDxHealth SA
- OPKO Diagnostics
- Pathway Genomics Corporation
- Sonic Healthcare
- Veracyte, Inc.
- Vermillion Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
